产品描述
| 溶解性 | Soluble in DMSO (100 mg/mL at 25 °C), water (<1 mg/mL at 25 °C), and ethanol (33 mg/mL at 25 °C). |
| 存贮条件 | 储存温度-20°C |
| 应用 | An orally-bioavailable, selective, potent inhibitor of B-Raf and VEGFR-2. |
| 产品介绍 | RAF265 (CHIR-265)是一种高度选择性的B-Raf和VEGFR2抑制剂，IC50为3-60 nM，也抑制VEGFR2磷酸化， EC50为30 nM，Phase 2。 |
| 备注 | RAF265 (CHIR-265) is a potent selective inhibitor of C-Raf/B-Raf/B-Raf V600E with IC50 of 3-60 nM, and exhibits potent inhibition on VEGFR2 phosphorylation with EC50 of 30 nM. Phase 2. |
| 生化机理 | RAF265 is an orally-bioavailable, selective, potent inhibitor of B-Raf and VEGFR-2 with IC50 of 3-60 nM and EC50 of 30 nM, respectively. |
| 别名 | 1-甲基-5-[[2-[5-(三氟甲基)-1H-咪唑-2-基]-4-吡啶基]氧基]-N-[4-(三氟甲基)苯基]-1H-苯并咪唑-2-胺;CHIR-265; RAF 265; RAF-265; CHIR265;RAF 265;RAF-265;CHIR265;1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine |
